The average treatment effect in the treated hazard ratio among those who received sotrovimab was 0.92 (95% confidence ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...